A 71-year-old woman contemplating a screening colonoscopy

JAMA

Volumn 295, Issue 10, 2006, Pages 1161-1167

  Taylor, William C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER SCREENING; CASE REPORT; COLON CANCER; COLONOSCOPY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 33644808681     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.10.1161     Document Type: Article

References (76)

1. Jo WS, Chung DC. Genetics of hereditary colorectal cancer. Semin Oncol. 2005;32:11-23.
2. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268.
3. Boyle P, Leon ME. Epidemiology of colorectal cancer. Br Med Bull. 2002;64:1-25.
4. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
5. SEER*Stat Databases: Incidence - SEER 11 Regs + AK Public-Use, Nov 2003 Sub for Expanded Races (1992-2001) and Incidence - SEER 11 Regs Public-Use, Nov 2003 Sub for Hispanics (1992-2001). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission. National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program Web site. Available at: http://www.seer.cancer.gov. Accessed February 4, 2006.
6. Willett WC. Diet and cancer: an evolving picture. JAMA. 2005;293:233-234.
7. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer - analysis of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78-85.
8. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology. 2003;124:544-560.
9. Fuchs CS, Giovannucci EL, Colditz GA, et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331:1669-1674.
10. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
11. Leslie A, Carey FA, Pratt N, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845-860.
12. Fearnhead NS, Wilding JL, Bodmer WF. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull. 2002;64:27-43.
13. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood [published correction appears in N Engl J Med. 1993;239:672]. N Engl J Med. 1993;328:1365-1371.
14. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1471.
15. Hardcastle JD, Camberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
16. Pignone M, Saha S, Hoerger T, Mendelblatt J. Cost-effectiveness of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:96-104.
17. Pignone M, Russell L, Wagner J, eds. Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary. Washington, DC: National Academy Press; 2005.
18. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:132-141.
19. Feld AD. Malpractice risks associated with colon cancer and inflammatory bowel disease. Am J Gastroenterol. 2004;99:1641-1644.
20. Podolsky DK. Going the distance - the case for true colorectal cancer screening. N Engl J Med. 2000;343:207-208.
21. Merenstein D. Winners and losers. JAMA. 2004;291:15-16.
22. Heiskanen I, Luostarinen T, Jarvinen HJ. Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol. 2000;35:1284-1287.
23. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829-834.
24. Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology. 2001;121:282-301.
25. Samowitz WS, Curtin K, Lin HH, et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology. 2001;121:830-838.
26. Selby JV, Friedman GD, Queensberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
27. Herrinton LJ, Selby JV, Friedman GD, Queensberry CP, Weiss NS. Casecontrol study of digital-rectal screening in relation to mortality from cancer of the distal rectum. Am J Epidemiol. 1995;142:961-964.
28. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society Guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin. 2001;51:38-75.
29. Collins JF, Lieberman DA, Durbin TE, et al. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med. 2005;142:81-85.
30. Ransohoff DF, Sandler RS. Clinical practice: screening for colorectal cancer. N Engl J Med. 2002;346:40-44.
31. Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 2005;352:2061-2068.
32. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954-1961.
33. Rockey DC, Paulson E, Niedzwiecki D, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet. 2005;365:305-311.
34. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med. 2000;342:1766-1772.
35. Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK consultant radiologists 1992 to 1994. Clin Radiol. 1997;52:142-148.
36. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: a case-control study among veterans. Arch Intern Med. 1995;155:1741-1748.
37. Pickhardt PJ, Nugent PA, Mysliwiec PA, Choi JR, Schindler WR. Location of adenomas missed by optical colonoscopy. Ann Intern Med. 2004;141:352-359.
38. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24-28.
39. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Fecal DNA versus fecal occult blood for colon-cancer screening in an average-risk population. N Engl J Med. 2004;351:2704-2714.
40. Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med. 2005;142:635-650.
41. Gluecker TM, Johnson CD, Wilson LA, et al. Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology. 2003;124:911-916.
42. Barish MA. The economics of virtual colonoscopy. Decisions in Imaging Economics. December 2001. Available at: http://www.imagingeconomics.com/library/ 200112-09.asp. Accessibility verified February 1, 2006.
43. Lieberman D. Colonoscopy: as good as gold? Ann Intern Med. 2004;141:401-403.
44. Balluz L, Ahluwalia IB, Murphy W, et al. Surveillance for certain health behaviors among selected local areas - United States, Behavioral Risk Factor Surveillance System, 2002. MMWR Surveill Summ. 2004;53:1-100.
45. Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med. 2005;142:86-94.
46. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: is mortality reduced by chance selection for screening colonoscopy? JAMA. 1994;271:1011-1013.
47. Haug U, Brenner H. A simulation model for colorectal cancer screening: potential of stool test with various performance characteristics compared with screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 2005;14:422-428.
48. Ederer F, Church TR, Mandel JS. Fecal occult blood screening in the Minnesota study: role of chance detection of lesions. J Natl Cancer Inst. 1997;89:1423-1428.
49. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge DJ, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169-174.
50. Iannaccone R, Laghi A, Catalano C, et al. Computed tomographic colonography without cathartic preparation for the detection of colorectal polyps. Gastroenterology. 2004;127:1300-1311.
51. Pickhardt PJ, Choi JR, Hwant I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003;349:2191-2200.
52. Sackett DL. Screening in family practice: prevention, levels of evidence, and the pitfalls of common sense. J Fam Pract. 1987;24:233-234.
53. Welch HG, Albertsen PC, Nease RF, et al. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med. 1996;124:577-584.
54. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285:2750-2756.
55. American Geriatrics Society Ethics Committee. Health screening decisions for older adults: AGS position paper. J Am Geriatr Soc. 2003;51:270-271.
56. Yarnall KSH, Pollack KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93:635-641.
57. Brennan TA, Mello MM. Patient safety and medical malpractice: a case study. Ann Intern Med. 2003;139:267-273.
58. Chatrenet P, Friocourt P, Ramain JP, Cherrier M, Maillard JB. Colonoscopy in the elderly: a study of 200 cases. Eur J Med. 1993;2:411-413.
59. Miller K. A case manager's perspective of patient transport. Case Manager. 2004;(spec No.):S2-S4.
60. Vasen HF, Boland CR. Progress in genetic testing, classification, and identification of Lynch syndrome. JAMA. 2005;293:2028-2030.
61. Gay G, Delvaux M, Rey JF. The role of video capsule endoscopy in the diagnosis of digestive diseases: a review of current possibilities. Endoscopy. 2004;36:913-920.
62. Grady C. Ethics and genetic testing. Adv Intern Med. 1999;44:389-411.
63. Taylor WC, Delbanco TL. Looking for early cancer. Ann Intern Med. 1980;93:773-775.
64. Angell M. Is academic medicine for sale? N Engl J Med. 2000;342:1516-1518.
65. Taylor WC, Makadon HJ, Delbanco TL. The periodic health examination of the adult. In: Noble J, ed. Textbook of General Medicine and Primary Care. Boston, Mass: Little Brown & Co; 1987:41-51.
66. Taylor WC. Questions and answers: indirect laryngoscopy as a screening test for laryngeal cancer. JAMA. 1991;265:3011-3014.
67. Meyer KB, Pauker SB. Screening for HIV: can we afford the false positive rate? N Engl J Med. 1987;317:238-241.
68. Lynch HT, Lynch PM. Molecular screening for the Lynch syndrome - better than family history? [editorial]. N Engl J Med. 2005;352:1920-1922.
69. ABIM Foundation; American Board of Internal Medicine; ACP-ASIM Foundation; American College of Physicians-American Society of Internal Medicine; European Federation of Internal Medicine. Medical professionalism in the new millennium: a physician charter. Ann Intern Med. 2002;136:243-246.
70. Woolf SH. A smarter strategy? reflections on fecal DNA screening for colorectal cancer. N Engl J Med. 2004;351:2755-2758.
71. Farmer P. Pathologies of power: rethinking health and human rights. Am J Public Health. 1999;89:1486-1496.
72. Forrow L, Wartman SA, Brock DW. Science, ethics, and the making of clinical decisions. JAMA. 1988;259:3161-3167.
73. Winawer SJ. Screening sigmoidoscopy: can the road to colonoscopy be less traveled? Ann Intern Med. 2003;139:1034-1035.
74. Pauker SG. Decision making and the principles of screening for breast cancer. J Gerontol. 1992;47(Spec No):142-147.
75. Sondhi M, Goffin JR, Cohen BJ, Wong JB, Pauker SG. DEALE-ing with lung cancer and heart failure. Med Decis Making. 2005;25:82-94.
76. Welch HG. Should I Be Tested for Cancer? Maybe Not and Here's Why. Berkeley: University of California Press; 2004.